Checkpoint Therapeutics, Inc.
SEC CIK 1651407 · CKPT · last insider filing 2025-06-03
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Weiss Michael S | Director · Exec. Chairman of the Board | filed 2016 - 2025 |
| Herskowitz Neil | Director | filed 2016 - 2025 |
| Bechon Christian | Director | filed 2018 - 2025 |
| Salzman Barry M | Director | filed 2016 - 2025 |
| Oliviero James F III | Director · CEO, President and Director | filed 2016 - 2025 |
| Amit Sharma | Director | filed 2024 - 2025 |
| Rosenwald Lindsay A MD | Director | filed 2016 - 2025 |
| Boilen Scott | Director | filed 2016 - 2023 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Gray William Garrett | See Remarks | filed 2016 - 2025 |
| Horin David J | Interim CFO | filed 2016 - 2016 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.